IP Library Assignment 051882/0260
Patent Assignment
Reel/Frame 051882/0260

Release of Security Interest

Recorded: 2020-02-20 Pages: 8
Assignor
Assignee
DERMIRA, INC.
275 MIDDLEFIELD ROAD, SUITE 150, MENLO PARK, CALIFORNIA, 94025
Covered Properties (40)
Glycopyrrolate Salts
Application: 15/996,353 →
Publication: US US20180271833A1
Dermatological Formulations of 2-(2-Ethoxy-2-Oxoethyl)(Methyl)Amino-2-Oxoethyl 5-(Tetradecyloxy)Furan-2-Carboxylate
Application: 15/660,520 →
Publication: US US20180028487A1
Process for Production of Glycopyrronium Tosylate
Application: 16/370,760 →
Publication: US US20190225580A1
Topical Glycopyrrolate Formulations
Application: 15/994,232 →
Publication: US US20180311116A1
Antibody Formulations
Application: 16/002,932 →
Publication: US US20190002552A1
Method for Treating Hyperhidrosis in Mammals
Application: 90/006,468 →
Integrin Linked Kinase Modulation of Monocyte Activation
Patent: 7,504,228 →
Application: 10/163,599 →
Publication: US US20050220779A1
Crystalline Glycopyrrolate Tosylate
Patent: 8,558,008 →
Application: 13/781,390 →
Publication: US US20130211101A1
Crystalline Glycopyrrolate Tosylate
Patent: 9,006,461 →
Application: 14/024,480 →
Publication: US US20140243535A1
Crystalline Glycopyrrolate Tosylate
Patent: 8,859,610 →
Application: 14/024,484 →
Publication: US US20140242122A1
Glycopyrrolate Salts
Patent: 9,006,462 →
Application: 14/473,537 →
Publication: US US20140371290A1
Glycopyrrolate Salts
Patent: 9,259,414 →
Application: 14/643,553 →
Publication: US US20150196532A1
Glycopyrrolate Salts
Patent: 9,610,278 →
Application: 14/989,995 →
Publication: US US20160113902A1
Glycopyrrolate Salts
Application: 15/438,636 →
Publication: US US20170157088A1
Process for Production of Glycopyrronium Tosylate
Patent: 9,926,270 →
Application: 14/830,638 →
Publication: US US20160052879A1
Process for Production of Glycopyrronium Tosylate
Application: 15/895,685 →
Publication: US US20180186735A1
Device and Method for Dispensing a Drug
Application: 15/146,627 →
Publication: US US20160243345A1
Synthetic Process for Preparing 2-Furoic Acid Derivatives
Patent: 9,975,867 →
Application: 15/015,569 →
Publication: US US20160229825A1
Synthetic Process for Preparing 2-((2-Ethoxy-2-Oxoethyl)(Methyl)Amino)-2-Oxoethyl 5-Tetradecyloxy)Furan-2-Carboxylate
Patent: 9,487,497 →
Application: 15/015,828 →
Publication: US US20160229826A1
Synthetic Process for Preparing 2-((2-Ethoxy-2-Oxoethyl)(Methyl)Amino)-2-Oxoethyl 5-Tetradecyloxy)Furan-2-Carboxylate
Patent: 9,745,277 →
Application: 15/284,319 →
Publication: US US20170022176A1
Glycopyrrolate Salts
Application: 16/235,120 →
Publication: US US20190133999A1
Method for Treating Hot Flashes in Humans
Patent: 5,962,505 →
Application: 09/184,512 →
Method for Treating Hot Flashes in Humans
Patent: 6,395,757 →
Application: 09/360,074 →
Topical Glycopyrrolate Formulations
Patent: 8,618,160 →
Application: 12/738,168 →
Publication: US US20100276329A1
Topical Glycopyrrolate Formulations
Patent: 9,744,105 →
Application: 14/084,010 →
Publication: US US20140151255A1
Topical Glycopyrrolate Formulations
Application: 15/662,166 →
Publication: US US20180008517A1
Novel Anti-Il 13 Antibodies and Uses Thereof
Patent: 8,088,618 →
Application: 12/240,604 →
Publication: US US20110014199A1
Novel Anti-IL13 Antibodies and Uses Thereof
Patent: 8,734,801 →
Application: 13/275,684 →
Publication: US US20120156203A1
Novel Anti-IL13 Antibodies and Uses Thereof
Patent: 9,067,994 →
Application: 13/308,186 →
Publication: US US20120214971A1
Novel Anti-IL13 Antibodies and Uses Thereof
Patent: 9,605,065 →
Application: 13/971,394 →
Publication: US US20140105897A1
Antibody Formulations
Application: 14/259,882 →
Publication: US US20140348855A1
Methods and Compositions Comprising Purified Recombinant Polypeptides
Patent: 9,920,120 →
Application: 15/065,693 →
Publication: US US20160319012A1
Method for Treating Hyperhidrosis in Mammals
Patent: 6,433,003 →
Application: 09/552,011 →
Novel Anti-IL13 Antibodies and Uses Thereof
Patent: 8,067,199 →
Application: 10/583,927 →
Publication: US US20090214523A1
Processes for Making, and Methods of Using, Glycopyrronium Compounds
Dermatological Formulations of 2-(2-Ethoxy-2-Oxoethyl)(Methyl)Amino-2-Oxoethyl 5-(Tetradecyloxy)Furan-2-Carboxylate
Antibody Formulations
Methods and Compositions Comprising Purified Recombinant Polypeptides
Uses of Il-13 Antagonists for Treating Atopic Dermatitis
Device and Method for Dispensing a Drug
Patent: 9,440,056 →
Application: 14/869,799 →
Publication: US US20160089526A1
Related Assignments (20)
Other recorded transfers of the patents in this record — the chain of ownership.
Merger Nov 24, 2008
From: KINETEK PHARMACEUTICALS, INC.; QLT INC.
To: QLT INC.
Reel/Frame 021884/0444 →
Assignment of Assignor's Interest Mar 1, 2013
From: STATLER, JOHN ALLAN; SHAW, ANTHONY ADRIAN; IMBERT, DELPHINE CAROLINE
To: DERMIRA, INC.
Reel/Frame 029903/0112 →
Assignment of Assignor's Interest Mar 1, 2013
From: APTUIT (WEST LAFAYETTE), LLC
To: DERMIRA, INC.
Reel/Frame 029903/0163 →
Assignment of Assignor's Interest Mar 1, 2013
From: ANDRES, PATRICIA; MCQUEEN, LISA LYNN; NELSON, JENNIFER LEIGH; BOERRIGTER, STEPHAN XANDER MATTHEUS
To: APTUIT (WEST LAFAYETTE), LLC
Reel/Frame 029903/0140 →
Assignment of Assignor's Interest Sep 12, 2013
From: ANDRES, PATRICIA; MCQUEEN, LISA LYNN; NELSON, JENNIFER LEIGH; BOERRIGTER, STEPHAN XANDER MATTHEUS
To: APTUIT, LLC
Reel/Frame 031191/0206 →
Assignment of Assignor's Interest Sep 12, 2013
From: ANDRES, PATRICIA; MCQUEEN, LISA LYNN; NELSON, JENNIFER LEIGH; BOERRIGTER, STEPHAN XANDER MATTHEUS
To: APTUIT LLC
Reel/Frame 031191/0096 →
Assignment of Assignor's Interest Sep 12, 2013
From: STATLER, JOHN ALLAN; IMBERT, DELPHINE CAROLINE; SHAW, ANTHONY ADRIAN
To: DERMIRA, INC.
Reel/Frame 031191/0178 →
Assignment of Assignor's Interest Sep 12, 2013
From: STATLER, JOHN ALLAN; IMBERT, DELPHINE CAROLINE; SHAW, ANTHONY ADRIAN
To: DERMIRA, INC.
Reel/Frame 031191/0222 →
Assignment of Assignor's Interest Sep 17, 2013
From: APTUIT LLC
To: DERMIRA, INC.
Reel/Frame 031222/0898 →
Assignment of Assignor's Interest Sep 17, 2013
From: APTUIT, LLC
To: DERMIRA, INC.
Reel/Frame 031222/0904 →
Assignment of Assignor's Interest Jan 12, 2015
From: STATLER, JOHN ALLAN; SHAW, ANTHONY ADRIAN; IMBERT, DELPHINE CAROLINE; NELSON, JENNIFER LEIGH
To: DERMIRA, INC.
Reel/Frame 034684/0826 →
Assignment of Assignor's Interest Jan 21, 2015
From: MCQUEEN, LISA LYNN
To: DERMIRA, INC.
Reel/Frame 034768/0529 →
Assignment of Assignor's Interest Mar 10, 2015
From: STATLER, JOHN ALLAN; SHAW, ANTHONY ADRIAN; IMBERT, DELPHINE CAROLINE; NELSON, JENNIFER LEIGH
To: DERMIRA, INC.
Reel/Frame 035130/0115 →
Assignment of Assignor's Interest Oct 9, 2015
From: SHAW, ANTHONY ADRIAN; VIGANO, ENRICO; MOLTENI, RENATO
To: DERMIRA, INC.
Reel/Frame 036768/0737 →
Assignment of Assignor's Interest Jan 7, 2016
From: STATLER, JOHN ALLAN; SHAW, ANTHONY ADRIAN; IMBERT, DELPHINE CAROLINE; NELSON, JENNIFER LEIGH
To: DERMIRA, INC.
Reel/Frame 037430/0440 →
Assignment of Assignor's Interest Aug 21, 2017
From: SHAW, ANTHONY ADRIAN; KHUMTAVEEPORN, KANJAI; KRASIK, PAVEL
To: DERMIRA INC
Reel/Frame 043343/0740 →
Security Interest Dec 7, 2018
From: DERMIRA, INC.
To: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
Reel/Frame 047701/0465 →
Security Interest Aug 28, 2019
From: DERMIRA, INC.
To: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
Reel/Frame 050194/0212 →
Assignment of Assignor's Interest Jul 12, 2021
From: DERMIRA, INC.
To: JOURNEY MEDICAL CORPORATION
Reel/Frame 056829/0767 →
Security Interest Dec 28, 2023
From: JOURNEY MEDICAL CORPORATION; JG PHARMA, INC.
To: SWK FUNDING LLC
Reel/Frame 066157/0079 →